Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Relationship Between Body Weight and Glycohemoglobin
A completed trial investigating the relationship between body weight and glycohemoglobin (HbA1c) in people with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2009-05-01Clinical Trial Update: Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED) [Phase 3]
A Phase 3 trial evaluating sitagliptin in older adults with Type 2 diabetes has completed and posted results.
-
FDA label_change · 2009-05-01FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for glyburide, resulting in a labeling update for the generic product.
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating the effect of Abbott Nutrition's nutritional products on blood glucose in adults with Type 2 diabetes has completed…
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: A Lifestyle Change Program to Prevent Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating a lifestyle change program to prevent Type 2 diabetes in people with prediabetes. Results were posted in 2009.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: GALLANT 2 Tesaglitazar vs. Placebo [Phase 3]
A Phase 3 trial (GALLANT 2) evaluating tesaglitazar versus placebo in type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: GALLANT 8 Tesaglitazar Add-on to Metformin [Phase 3]
Phase 3 trial evaluating Tesaglitazar added to Metformin for Type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate [Phase 3]
A Phase 3 trial (GALLANT 14) evaluating tesaglitazar versus metformin and fenofibrate has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin [Phase 3]
A Phase 3 trial assessing tesaglitazar in combination with insulin for Type 2 Diabetes Mellitus was terminated; no efficacy results are repo…
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Dose Response Study in Japanese Patients [Phase 2]
Phase 2 dose-response trial in Japanese patients with Type 2 Diabetes sponsored by AstraZeneca was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-22Clinical Trial Update: Effects of Qigong on Type 2 Diabetic Patients [NA]
A completed clinical trial studied the effects of Qigong on patients with Type 2 diabetes. Results were posted in 2009 by Bastyr University.
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients [Phase 3]
Clinical trial update reports the completion of a Phase 3 study evaluating rimonabant in drug-naive patients with Type 2 Diabetes Mellitus. …
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Obese Patients With Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update for obese patients with type 2 diabetes has completed, sponsored by Sanofi.
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) [Phase 3]
This report notes a Phase 3 trial evaluating insulin glargine in insulin-naive adults with type 2 diabetes who are taking oral glucose-lower…
-
CLINICAL_TRIALS trial_result · 2009-04-17Clinical Trial Update: Does a Low-Fat Vegetarian Diet Improve Insulin Resistance in Individuals With Type 2 Diabetes? [Phase 1]
A Phase 1 trial tested whether a low-fat vegetarian diet improves insulin resistance in individuals with Type 2 diabetes and has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-15Clinical Trial Update: An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers [Phase 1]
Phase 1 ascending multi-dose tolerance and pharmacokinetic study in overweight/obese individuals with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-15Clinical Trial Update: A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers [Phase 1]
This document reports a Phase 1 single-dose tolerability and pharmacokinetic study in overweight or obese volunteers with Type 2 diabetes me…
-
CLINICAL_TRIALS trial_result · 2009-04-10Clinical Trial Update: Genetic Physiopathology and Evolution of Type 2 Diabetes
This completed University of Pisa clinical trial investigates the genetic physiopathology and evolution of prediabetes toward type 2 diabete…
-
CLINICAL_TRIALS research · 2009-04-10Clinical Trial Update: To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension [Phase 1]
A Phase 1 clinical trial update from AstraZeneca evaluating the hormonal response to hypoglycemia after a single oral dose of AZD1656 suspen…
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO) [Phase 3]
Phase 3 clinical trial evaluating the efficacy of rimonabant in insulin-treated patients with Type 2 Diabetes Mellitus (ARPEGGIO) conducted …
-
CLINICAL_TRIALS research · 2009-04-06Clinical Trial Update: Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus [NA]
A clinical trial update examining whether glucagon inhibition modifies the anti-diabetic effect of GLP-1 in patients with Type 2 Diabetes Me…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED) [Phase 3]
Clinical trial update reports completion and posted results for a Phase 3 add-on study evaluating sitagliptin in combination with pioglitazo…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients [Phase 4]
Phase 4 trial comparing insulin glargine to NPH insulin in adults with type 2 diabetes to assess progression of diabetic retinopathy; the st…
-
FDA approval · 2009-03-25FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental ANDA for Apotex Corp. to market GLIPIZIDE as a generic tablet for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia [Phase 2]
A Phase 2 trial comparing prolonged-release melatonin with placebo in adults with type 2 diabetes and insomnia; results have been completed …